Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Banco de datos
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
Clin Res Cardiol ; 110(3): 313-322, 2021 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-32844282

RESUMEN

Transcatheter aortic valve implantation (TAVI) is an accepted treatment approach of aortic stenosis. In the beginning, this technique was executed in high-risk patients only. Today, intermediate-risk patients are also amenable for TAVI, as long as the transfemoral approach is chosen. Numerous predictors have been identified that could lead to periprocedural complications and are defined by patient co-morbidities as well as being inherent to the technical approach. Although vascular complications and postinterventional paravalvular regurgitation have been minimized over the past years by revised technologies and techniques, there is a prevailing individual risk brought about by the specific pathophysiology of the cardiorenal syndrome.


Asunto(s)
Lesión Renal Aguda/etiología , Estenosis de la Válvula Aórtica/cirugía , Tasa de Filtración Glomerular/fisiología , Prótesis Valvulares Cardíacas/efectos adversos , Riñón/fisiopatología , Complicaciones Posoperatorias/etiología , Reemplazo de la Válvula Aórtica Transcatéter/efectos adversos , Lesión Renal Aguda/epidemiología , Salud Global , Humanos , Incidencia , Complicaciones Posoperatorias/epidemiología , Factores de Riesgo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA